PPT-Data source: Medicare 5 percent sample. January 1, 2013 point prevalent patients aged
Author : riley | Published Date : 2023-06-23
Adj agesexrace Ref all patients 2013 Abbreviation CKD chronic kidney disease Table 31 Unadjusted and adjusted allcause mortality rates per 1000 patient years at
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Data source: Medicare 5 percent sample. ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Data source: Medicare 5 percent sample. January 1, 2013 point prevalent patients aged: Transcript
Adj agesexrace Ref all patients 2013 Abbreviation CKD chronic kidney disease Table 31 Unadjusted and adjusted allcause mortality rates per 1000 patient years at risk for Medicare patients aged 66 and older by CKD status 2013. 2017 . Annual Data Report. Volume . 1: Chronic Kidney . Disease. 2. . Unadjusted. . Adjusted. No CKD. All CKD. . No CKD. All CKD. All. 43.8. 134.8. . 45.6. 109.7. Age. . . . . . 66–69. Volume 1: Chronic Kidney Disease. Chapter 2: Identification and Care of Patients With CKD. 2. Table A. ICD-9-CM and ICD-10-CM codes for Chronic Kidney Disease (CKD) . stages (introduced . in 2006). Table A. ICD-9-CM and ICD-10-CM codes for Chronic Kidney Disease (CKD) stages. Figure i.1 Prevalence of CKD by stage among NHANES participants, 1988-2012. Vol . 1, CKD, . Ch. . i. 2. Stages of CKD – KDOQI 2002 Definitions. Stage 1: eGFR ≥ 90 ml/min/1.73m. 2. and ACR ≥ 30 mg/g. Volume 1: Chronic Kidney Disease. 2018 Annual Data Report . Volume . 1 CKD, . Chapter 3. Chapter 3:. Morbidity and Mortality. 2. vol. 1 Table 3.1 Unadjusted and adjusted all-cause mortality rates per 1,000 patient-years at risk for Medicare patients aged 66 and older, by CKD status, 2016. valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . 2016 Annual Data Report, Vol . 1, CKD, . Ch. . 3. 2. Data source: Medicare 5 percent sample. January 1, 2014 point prevalent patients aged 66 and older. . Adj. : age/sex/race. Ref: all patients, 2014. Abbreviation: CKD, chronic kidney disease.. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2007–2012 participants aged 20 & older. Whisker lines indicate 95% confidence intervals. Abbreviations: CKD, chronic kidney disease. This graphic also appears as Figure 1.2. Vol. 1, CKD, . Ch. . 6. 2. Data source: Medicare 5 percent sample. Abbreviations: CKD, chronic kidney disease; CHF, congestive heart failure, DM, diabetes mellitus.. v. ol 1 Table . 6.1 Point prevalent distribution of Medicare fee-for-service patients aged 65+ and total annual costs of Medicare Parts A and B services, by DM, CHF, and/or CKD, 2012. Vol. 1, CKD, . Ch. 2. 2. Table A. ICD-9-CM Codes. 585.1. Chronic kidney disease, Stage 1. 585.2. Chronic kidney disease, Stage 2 (mild). 585.3. Chronic kidney disease, Stage 3 (moderate). 585.4. Chronic kidney disease, Stage 4 (severe). Adj. : age/sex/race/prior year hospitalization/comorbidities. Ref: 2012 patients. Abbreviations: CKD, chronic kidney disease.. vol 1 Figure 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years at risk) for Medicare patients aged 66 and older, by CKD status and year, . Figure . 7.1 . Sources of prescription drug coverage in Medicare enrollees, by population, 2014. 2016 Annual Data Report, Vol 1, CKD, Ch . 7. 2. a The . catastrophic coverage amount is the greater of 5% of medication cost or the values shown in the chart above. In 2014, beneficiaries were charged $2.55 for those generic or preferred multisource drugs with a retail price less than $51 and 5% for those with a retail price over $51. For brand name drugs, beneficiaries paid $6.35 for those drugs with a retail price less than $127 and 5% for those with a retail price over $127. Table adapted from http://www.q1medicare.com/PartD-The-2014-Medicare-Part-D-Outlook.php. . valvular. heart disease; VTE/PE, venous thromboembolism and pulmonary embolism.. Figure . 4.1 Prevalence . of cardiovascular diseases in patients with or without CKD, 2014 . . 2016 Annual Data Report, Vol 1, CKD, . Af. Am, African American; AKI, acute kidney injury; CKD, chronic kidney disease.. vol. 2 Table 2.1 HP2020 CKD-3 Increase the proportion of hospital patients who incurred acute kidney injury who have follow-up renal evaluation in 6 months post-discharge: Target 12.3%.
Download Document
Here is the link to download the presentation.
"Data source: Medicare 5 percent sample. January 1, 2013 point prevalent patients aged"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
